Answer in brief
CVE-2023-38955 records a High severity (CVSS 7.5) missing auth vulnerability in CVE-2023-38955. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
Review the upstream advisory, identify the affected product in your inventory, and apply the vendor update when one is available.
Answer in brief
CVE-2023-38955 records a High severity (CVSS 7.5) missing auth vulnerability in CVE-2023-38955. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
Review the upstream advisory, identify the affected product in your inventory, and apply the vendor update when one is available.
Missing Auth describes the vulnerability class recorded for this advisory. The current record does not mark CVE-2023-38955 as known exploited; continue to monitor the source for status changes. This is a product-level record in the current feed, not a package-level dependency mapping.
Affected software not mapped. Review the upstream record for vendor-specific product and version guidance.
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
Reported by NVD (nvd).
CVE-2023-38955 records a High severity (CVSS 7.5) missing auth vulnerability in CVE-2023-38955. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
The source record does not mark it as known exploited.
Confirm whether the product or interface named by this advisory exists in your inventory.
HOL Guard can help your team monitor supply-chain activity while the upstream record is clarified.
Explore HOL GuardMissing Auth describes the vulnerability class recorded for this advisory. The current record does not mark CVE-2023-38955 as known exploited; continue to monitor the source for status changes. This is a product-level record in the current feed, not a package-level dependency mapping.
Affected software not mapped. Review the upstream record for vendor-specific product and version guidance.
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
Reported by NVD (nvd).
CVE-2023-38955 records a High severity (CVSS 7.5) missing auth vulnerability in CVE-2023-38955. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
The source record does not mark it as known exploited.
Confirm whether the product or interface named by this advisory exists in your inventory.
HOL Guard can help your team monitor supply-chain activity while the upstream record is clarified.
Explore HOL Guard